PRCT vs. SOLV, SNN, PEN, GKOS, STVN, BLCO, INSP, NARI, NVST, and IRTC
Should you be buying PROCEPT BioRobotics stock or one of its competitors? The main competitors of PROCEPT BioRobotics include Solventum (SOLV), Smith & Nephew (SNN), Penumbra (PEN), Glaukos (GKOS), Stevanato Group (STVN), Bausch + Lomb (BLCO), Inspire Medical Systems (INSP), Inari Medical (NARI), Envista (NVST), and iRhythm Technologies (IRTC). These companies are all part of the "medical equipment" industry.
PROCEPT BioRobotics vs.
Solventum (NYSE:SOLV) and PROCEPT BioRobotics (NASDAQ:PRCT) are both medical companies, but which is the better stock? We will compare the two businesses based on the strength of their risk, dividends, institutional ownership, earnings, valuation, media sentiment, profitability, community ranking and analyst recommendations.
89.5% of PROCEPT BioRobotics shares are owned by institutional investors. 17.4% of PROCEPT BioRobotics shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock will outperform the market over the long term.
Solventum has higher earnings, but lower revenue than PROCEPT BioRobotics.
Solventum currently has a consensus target price of $68.29, indicating a potential downside of 7.21%. PROCEPT BioRobotics has a consensus target price of $97.86, indicating a potential upside of 28.73%. Given PROCEPT BioRobotics' stronger consensus rating and higher probable upside, analysts clearly believe PROCEPT BioRobotics is more favorable than Solventum.
Solventum has a net margin of 0.00% compared to PROCEPT BioRobotics' net margin of -50.07%. Solventum's return on equity of 0.00% beat PROCEPT BioRobotics' return on equity.
In the previous week, PROCEPT BioRobotics had 1 more articles in the media than Solventum. MarketBeat recorded 8 mentions for PROCEPT BioRobotics and 7 mentions for Solventum. Solventum's average media sentiment score of 0.96 beat PROCEPT BioRobotics' score of 0.66 indicating that Solventum is being referred to more favorably in the media.
PROCEPT BioRobotics received 37 more outperform votes than Solventum when rated by MarketBeat users. Likewise, 67.86% of users gave PROCEPT BioRobotics an outperform vote while only 5.56% of users gave Solventum an outperform vote.
Summary
PROCEPT BioRobotics beats Solventum on 9 of the 13 factors compared between the two stocks.
Get PROCEPT BioRobotics News Delivered to You Automatically
Sign up to receive the latest news and ratings for PRCT and its competitors with MarketBeat's FREE daily newsletter.
New MarketBeat Followers Over Time
This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Media Sentiment Over Time
This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
PROCEPT BioRobotics Competitors List
Related Companies and Tools
This page (NASDAQ:PRCT) was last updated on 1/20/2025 by MarketBeat.com Staff
Free PRCT Stock Alerts